nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—Clonidine—SLC22A5—dilated cardiomyopathy	0.798	1	CrCbGaD
Lofexidine—ADRA2A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.0186	0.092	CbGpPWpGaD
Lofexidine—ADRA2A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0151	0.0746	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00838	0.0414	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00717	0.0355	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00704	0.0348	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00679	0.0335	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00658	0.0325	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00571	0.0282	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00553	0.0274	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00534	0.0264	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00511	0.0253	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00448	0.0222	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00428	0.0211	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00336	0.0166	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00304	0.015	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00264	0.013	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00224	0.0111	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.002	0.00986	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00193	0.00956	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00193	0.00956	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0018	0.00889	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0018	0.00887	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00173	0.00855	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00167	0.00825	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00162	0.00799	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TTN—dilated cardiomyopathy	0.00157	0.00775	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00154	0.0076	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00154	0.0076	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00152	0.00752	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00152	0.00752	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00143	0.00707	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00141	0.00699	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00141	0.00697	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00139	0.00685	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00138	0.00682	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.00136	0.00672	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00131	0.00648	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00131	0.00647	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00127	0.00628	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00121	0.00598	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00121	0.00598	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00118	0.00585	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00117	0.00579	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00117	0.00579	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.00116	0.00571	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00112	0.00556	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00112	0.00555	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00109	0.00538	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00109	0.00538	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00109	0.00536	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00105	0.00521	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00105	0.00517	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00103	0.00509	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00096	0.00474	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00093	0.00459	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000921	0.00455	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000921	0.00455	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000905	0.00447	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000901	0.00445	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000892	0.00441	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000882	0.00436	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000856	0.00423	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000855	0.00422	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000839	0.00414	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000832	0.00411	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000829	0.0041	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000823	0.00407	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000758	0.00375	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000708	0.0035	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000672	0.00332	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000662	0.00327	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000662	0.00327	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000659	0.00325	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000654	0.00323	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000634	0.00313	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000615	0.00304	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000601	0.00297	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000601	0.00297	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.0006	0.00296	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000596	0.00295	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.00058	0.00287	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000559	0.00276	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000541	0.00268	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00052	0.00257	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00052	0.00257	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000509	0.00252	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000498	0.00246	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000495	0.00245	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000484	0.00239	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000483	0.00239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000473	0.00234	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000473	0.00234	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000469	0.00232	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000466	0.0023	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000462	0.00228	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000439	0.00217	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000439	0.00217	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000425	0.0021	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0004	0.00198	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.0004	0.00198	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00038	0.00188	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000375	0.00185	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000363	0.0018	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000358	0.00177	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000355	0.00176	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000355	0.00176	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000345	0.0017	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00034	0.00168	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00033	0.00163	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000325	0.00161	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00032	0.00158	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000314	0.00155	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000309	0.00153	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000295	0.00146	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000282	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000279	0.00138	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000279	0.00138	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000273	0.00135	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000268	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00026	0.00128	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000259	0.00128	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000256	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000251	0.00124	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000226	0.00112	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000223	0.0011	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000215	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000206	0.00102	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000204	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000201	0.000994	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000201	0.000991	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000192	0.00095	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000181	0.000893	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000177	0.000877	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000175	0.000865	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000158	0.000781	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000155	0.000765	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000151	0.000746	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000133	0.000659	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000122	0.000601	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000105	0.000518	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	9.15e-05	0.000452	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	7.19e-05	0.000355	CbGpPWpGaD
